To include your compound in the COVID-19 Resource Center, submit it here.

Avelumab: Phase III started

Merck and Pfizer began the open-label, international Phase III JAVELIN Renal 101 trial to compare

Read the full 150 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE